Post-approval studies posted
This article was originally published in The Gray Sheet
FDA lists more than 40 clinical studies on a 1Web site that went live April 6 tracking the ongoing status of post-approval medical device data collection ordered by the agency since Jan. 1, 2005 (2"The Gray Sheet" April 2, 2007, p. 26)...
You may also be interested in...
A public Web site tracking device companies' progress on FDA-required post-approval studies is scheduled to go live April 6
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.